Recommended Topic Related To:

Asmanex

"What are allergies?

Allergies occur when the body's immune system responds to a substance it considers an "invader." Substances that provoke the immune system into an allergic response are known as allergens. There is no such thing as a"...

Asmanex Twisthaler

Indications
Dosage
How Supplied

INDICATIONS

Treatment of Asthma

ASMANEX® TWISTHALER® is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older.

Important Limitations of Use

ASMANEX TWISTHALER (mometasone furoate) is NOT indicated for the relief of acute bronchospasm. ASMANEX TWISTHALER is NOT indicated in children less than 4 years of age.

DOSAGE AND ADMINISTRATION

Administer ASMANEX TWISTHALER (mometasone furoate) by the orally inhaled route only. Instruct patients to inhale rapidly and deeply. Advise patients to rinse the mouth after inhalation. Individual patients will experience a variable time to onset and degree of symptom relief. Maximum benefit may not be achieved for 1 to 2 weeks or longer after initiation of treatment. After asthma stability has been achieved, it is desirable to titrate to the lowest effective dosage to reduce the possibility of side effects. For patients ≥ 12 years of age who do not respond adequately to the starting dose after 2 weeks of therapy, higher doses may provide additional asthma control. The safety and efficacy of ASMANEX TWISTHALER (mometasone furoate) when administered in excess of recommended doses have not been established.

Recommended Dosages in Patients 4 Years of Age and Older

The recommended starting doses and highest recommended daily dose for ASMANEX TWISTHALER treatment based on prior asthma therapy are provided in Table 1.

TABLE 1: Recommended Dosages for ASMANEX TWISTHALER (mometasone furoate) Treatment

Previous Therapy Recommended Starting Dose Highest Recommended Daily Dose
Patients ≥ 12 years who received bronchodilators alone 220 mcg once daily in the evening* 440 mcg**
Patients ≥ 12 years who received inhaled corticosteroids 220 mcg once daily in the evening* 440 mcg**880 mcg
Patients ≥ 12 years who received oral corticosteroids† 440 mcg twice daily
Children 4 – 11 years of age‡ 110 mcg once daily in the evening* 110 mcg*
* When administered once daily, ASMANEX TWISTHALER (mometasone furoate) should be taken only in the evening.
** The 440 mcg daily dose may be administered in divided doses of 220 mcg twice daily or as 440 mcg once daily.
† For Patients Currently Receiving Chronic Oral Corticosteroid Therapy: Prednisone should be reduced no faster than 2.5 mg/day on a weekly basis, beginning after at least 1 week of ASMANEX TWISTHALER (mometasone furoate) therapy. Monitor patients carefully for signs of asthma instability, including serial objective measures of airflow, and for signs of adrenal insufficiency during steroid taper and following discontinuation of oral corticosteroid therapy [see WARNINGS AND PRECAUTIONS].
‡Recommended pediatric dosage is 110 mcg once daily in the evening regardless of prior therapy.

HOW SUPPLIED

Dosage Forms And Strengths

ASMANEX TWISTHALER (mometasone furoate) is a dry powder for inhalation that is available in two strengths.

ASMANEX TWISTHALER 220 mcg delivers 200 mcg mometasone furoate per actuation from the mouthpiece.

ASMANEX TWISTHALER 110 mcg delivers 100 mcg mometasone furoate per actuation from the mouthpiece.

Storage And Handling

The ASMANEX TWISTHALER (mometasone furoate) 220 mcg product is comprised of an assembled plastic cap–activated dosing mechanism with dose counter, drug-product storage unit, drug-product formulation (240 mg), and mouthpiece, covered by a white screw cap that bears the product label. The body of the inhaler is white and the turning grip is pink with a clear plastic window indicating the number of doses remaining. The inhaler will not deliver subsequent doses once the counter reaches zero (“00”).

The ASMANEX TWISTHALER (mometasone furoate) 110 mcg product is comprised of an assembled plastic cap–activated dosing mechanism with dose counter, drug-product storage unit, drug-product formulation (135 mg), and mouthpiece, covered by a white screw cap that bears the product label. The body of the inhaler is white and the turning grip is gray with a clear plastic window indicating the number of doses remaining. The inhaler will not deliver subsequent doses once the counter reaches zero (“00”).

The ASMANEX TWISTHALER (mometasone furoate) product is available as:

ASMANEX TWISTHALER 220 mcg, which delivers 200 mcg mometasone furoate from the mouthpiece: 14 inhalation units (Institutional Use Only; NDC# 00851341-04); 30 inhalation units (NDC# 0085-1341-03); 60 inhalation units (For more than 1 inhalation daily; NDC# 0085-1341-02); or 120 inhalation units (For more than 2 inhalations daily; NDC# 0085-1341-01).

ASMANEX TWISTHALER (mometasone furoate) 110 mcg, which delivers 100 mcg mometasone furoate from the mouthpiece: 7 inhalation units (Institutional Use Only; NDC# 00851461-07); 30 inhalation units (NDC# 0085-1461-02).

Each inhaler is supplied in a protective foil pouch with Patient's Instructions for Use.

Store in a dry place at 25°C (77°F); excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature].

Discard the inhaler 45 days after opening the foil pouch or when dose counter reads “00”, whichever comes first.

Manufactured by Schering Corporation, a subsidiary of Schering-Plough Corporation, Kenilworth, NJ 07033 USA. U.S.

Last reviewed on RxList: 10/14/2010
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Asmanex Twisthaler - User Reviews

Asmanex Twisthaler User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Asmanex Twisthaler sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Allergies & Asthma

Improve treatments & prevent attacks.